Stock ALTME TME PHARMA N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Company TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Biotechnology & Medical Research

Real-time Euronext Paris
Other stock markets
 11:16:52 2024-04-23 am EDT 		5-day change 1st Jan Change
0.254 EUR 0.00% Intraday chart for TME Pharma N.V. -4.51% +10.43%
08:00am TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer CI
Apr. 03 TME Pharma: Fast Track designation in glioblastoma CF

Business Summary

TME Pharma N.V. is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. The company specializes in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Its unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma N.V.'s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. Its clinical programs in glioblastoma and pancreatic cancer have delivered very promising results and further development is planned.

Number of employees: 13

Managers

Managers TitleAgeSince
Aram Andrew Mangasarian CEO
 Chief Executive Officer 54 10-04-30
Heike Balzer DFI
 Director of Finance/CFO - 99-12-31
Ewelina Staniuk IRC
 Investor Relations Contact - 17-12-31
Karen Ophoff HRO
 Human Resources Officer - 00-12-31

Members of the board

Members of the board TitleAgeSince
Cornelis Alexander Izeboud BRD
 Director/Board Member 53 20-06-29
Maurizio PetitBon CHM
 Chairman 76 16-08-31
Susan Coles BRD
 Director/Board Member 58 21-06-23
Martine van Vugt BRD
 Director/Board Member 71 21-06-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,317,193 1,721,941 ( 32.38 %) 14,979 ( 0.2817 %) 32.38 %

Company contact information

TME Pharma NV

Max-Dohrn-Strasse 8-10

10589, Berlin

+

http://www.tmepharma.com
address TME Pharma N.V.(ALTME)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TME PHARMA N.V. Stock TME Pharma N.V.
+16.74% 7.69M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.02% 42.11B
LONZA GROUP AG Stock Lonza Group AG
+43.29% 40.08B
MODERNA, INC. Stock Moderna, Inc.
+5.04% 40B
CELLTRION, INC. Stock Celltrion, Inc.
-11.32% 26.87B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.25% 24.58B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.83% 18.44B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.62% 11.94B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+22.75% 11.66B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.44% 11.01B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALTME Stock
  4. Company TME Pharma N.V.